Peter Hunter
Corporate Officer/Principal presso Auckland University
Profilo
Peter Hunter is currently the Director of Computational Physiology at the University of Oxford and the Director of the Bioengineering Institute at Auckland University.
He previously worked as a Commercialization Manager at eBonz Ltd.
in 2011.
Posizioni attive di Peter Hunter
Società | Posizione | Inizio |
---|---|---|
Auckland University | Corporate Officer/Principal | 07/06/2011 |
University of Oxford | Corporate Officer/Principal | 07/06/2011 |
Precedenti posizioni note di Peter Hunter
Società | Posizione | Fine |
---|---|---|
eBonz Ltd.
eBonz Ltd. Pharmaceuticals: OtherHealth Technology eBonz was a startup company from the Auckland Bioengineering Institute involved in the development of functional 3D anatomically based models of the joints in the human body. eBonz develop patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. These models can be used by orthopedic device and insurance companies, and for education and training of patients and surgeons. eBonz was established in 2007 to take orthopedic modeling to market. It was built upon extensive research at the Auckland Bioengineering Institute (ABI) in the field of computational biomechanics. The ABI has an international reputation for innovative research and successful commercialization of ideas. eBonz continues to have a very close working relationship with the ABI. eBonz developed patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
eBonz Ltd.
eBonz Ltd. Pharmaceuticals: OtherHealth Technology eBonz was a startup company from the Auckland Bioengineering Institute involved in the development of functional 3D anatomically based models of the joints in the human body. eBonz develop patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. These models can be used by orthopedic device and insurance companies, and for education and training of patients and surgeons. eBonz was established in 2007 to take orthopedic modeling to market. It was built upon extensive research at the Auckland Bioengineering Institute (ABI) in the field of computational biomechanics. The ABI has an international reputation for innovative research and successful commercialization of ideas. eBonz continues to have a very close working relationship with the ABI. eBonz developed patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. | Health Technology |
- Borsa valori
- Insiders
- Peter Hunter